针对局部晚期直肠癌的量身定制治疗
Laudy Chehade1, Kristel Dagher1, Ali Shamseddine2
1Department of Internal Medicine, Division of Hematology/Oncology, Naef K. Basile Cancer Institute - NKBCI, American University of Beirut Medical Center, Beirut, Lebanon.
Cancer treatment and research communications
|October 17, 2024
概括
针对局部晚期直肠癌 (LARC) 的个性化治疗改善了结果. 进展包括非手术选择,量身定制的放射治疗和免疫治疗,特别是在MSI高的瘤中,提高直肠保护和生活质量.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 辐射瘤学 辐射瘤学
背景情况:
- 局部晚期直肠癌 (LARC) 管理需要个性化策略,以获得最佳的结果和患者的生活质量.
- 当前的治疗模式正在随着新的治疗方式和对瘤生物学的更深入理解而发展.
研究的目的:
- 审查LARC管理的最新进展.
- 探索非手术策略,放射疗法修改,化疗序列,以及新型药物的作用,如免疫疗法和支架疗法.
主要方法:
- 这篇叙事综述综合了关于LARC管理的当前文献.
- 研究的主要领域包括非手术管理,放射治疗选择 (LCCRT与SCRT),巩固化疗,免疫疗法和支臂疗法增强.
主要成果:
- 对于精选的LARC患者,非手术治疗是可行的.
- 长疗程化疗 (LCCRT) 与巩固化疗或支臂疗法增强改善了直肠保护.
- 高MSI的LARC显示单剂免疫疗法具有显著的益处;早期试验表明MSS瘤的潜力.
结论:
- 基于患者和瘤因素的个性化治疗分层对LARC至关重要.
- 量身定制的方法可以提高LARC管理中的瘤结果和生活质量.
- 像免疫疗法这样的新兴策略为LARC治疗提供了新的途径.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
126
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
126
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


